The IVD Market in South Korea, 2024
The IVD Market in South Korea, 2024 offers a comprehensive overview of the in vitro diagnostics (IVD) market in South Korea and the factors shaping it. The report presents South Korea's IVD revenues for 2023 and forecasts for 2028, segmented into clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC), and histology/cytology. Included in the report are trends influencing the industry and country-level data including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences.The report is designed to provide the reader with an overview of the IVD market in South Korea and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators, and controls of the following sub-segments:
- Clinical Chemistry: routine lab testing; substrates, enzymes, homogeneous immunoassays, proteins, ISE (non-POC), HBA1c (non-POC). Includes urinalysis and blood chemistry testing. Hematology and hemoglobin tests are also included in this segment.
- Immunoassays: hormones and thyroid function, tumor markers, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT, toxicology and common infectious diseases (HIV, hepatitis, influenza).
- Microbiology and Molecular Testing: manual and automated tests, culture media (to be prepared or ready to use), latex tests, transport media, blood culture, sensitivity discs, Gram and other stains, MTB culture, Mycoplasma, Ureaplasma, nucleic acid testing.
- Point-of-Care Testing: all POC tests for cardiology, toxicology, coagulation, diabetes, infectious diseases. Includes POC and non-POC blood gas and electrolytes. Also includes glucose self-monitoring tests.
- Histology/Cytology: PAP, HE, IHC, ISH, FISH, primary and secondary antibodies.
The information in the report was gathered using both primary and secondary research methods including interviews with industry participants and representatives, completed during the period of January 2024 and February 2024. These interviews were with government officials, medical device regulators, domestic-based distributors, health care providers and global market participants. Secondary data included the use of government databases, company literature, medical journals and reports.
All market data pertains to the South Korean IVD market at the manufacturers' level. Market data is presented for the 2023 year with forecast data provided for 2028. Compound annual growth rates (CAGRs) are provided for the 2023-2028 period.
- Executive Summary
- Industry Overview
- Scope and Methodology
- South Korea IVD Market Summary
- Table South Korea In Vitro Diagnostic Sales by Market Segment, 2023-2028 ($M)
- Company Profiles
- South Korea Overview
- Population
- Table Total Midyear Population by Broad Age Group: South Korea, 2010-2050 (million persons)
- Table Total Midyear Population by Broad Age Group: South Korea, 2010-2050 (million persons)
- Table Total Number of Births in South Korea, by Year, 1990-2010 and Forecast 2020-2050
- Table South Korea Life Expectancy at Birth in Years, 2010-2050
- Health Indicators
- General Health
- Disease Profiles in South Korea
- Table Number of Deaths Attributed to Non-Communicable Diseases, by Type of Disease, All Sexes, 2019
- Table Top 5 Cancers Affecting South Korean Population (ranked by total number of cases), 2020
- Table Tuberculosis - New and Relapse Case Notifications, 2000-2021
- Economy and Health Spending
- Table South Korea GDP, GDP (PPP) and Health Spending, 1990-2020 ($B)
- Table South Korea Distribution of Income or Consumption by Quintile, 2011-2016
- Health Infrastructure
- Table Healthcare System in Korea
- Medical Facilities
- Table Hospital Bed Density per 1,000 Population, by Country, 2023 Estimates
- Physicians
- Table Physician Density per 1,000 Population, by Country, 2023 Estimates
- Medical Tourism
- Table South Korea Medical Tourism Visits Reported, 2009-2021 (# of patients)
- Medical Device Regulation
- Table Medical Device Approval Process, South Korea
- Precision Medicine and NGS
- Physician Shortage in South Korea
- Table Market Divers and Inhibitors for Entering South Korea's Medical Device Market
- Table South Korea Medical Device Market Growth as a Global Comparison, 2023-2028 CAGR (%)
- Population
- IVD Markets in South Korea
- Market Summary
- Table South Korea In Vitro Diagnostic Sales, by Extracted Market Segment (Blood Bank Screening Immunoassays, Blood Gas Analysis, Blood Screening NAT, CTC, General Chemistry, Hematology, Hemoglobin, HPV, ID/AST, Infectious Disease Immunoassays, Microbiology Molecular, Non-infectious Disease Immunos, Other Histology, POC Glucose, POC Infectious Disease, POC Other, Urinalysis, Others), 2023-2028 ($M)
- Table South Korea In Vitro Diagnostic Sales, by Broad Market Segment (Clinical Chemistry, Histology, Immunoassay, Microbiology, POC, Other), 2023-2028 ($M)
- Table South Korea In Vitro Diagnostic Sales, by Broad Market Segment (Clinical Chemistry, Histology, Immunoassay, Microbiology, POC, Other), 2023 Market Distribution (%)
- Clinical Chemistry
- Table South Korea - Clinical Chemistry Market (Blood Gas Analysis, General Chemistries, Hematology, Hemoglobin, Urinalysis), 2023-2028
- Immunoassay
- Table South Korea Immunoassay Infectious Disease Market Distribution, by Disease (Blook Bank Screening Immunos, HAIs/Sepsis, Hepatitis, HIV, Mycology, Parasitology, Respiratory [w/ COVID], STD, ToRCH, Other [EBV, Chagas, Dengue, Malaria, etc.]), 2023 (%)
- Table South Korea - Immunoassay Market Value, by Segment (Blood Bank Screening, Infectious Disease, Non-infectious Disease), 2023-2028 ($M)
- Microbiology/Molecular
- Table South Korea ID/AST Manual, Auto Market Distribution, 2023 (%)
- Table South Korea Molecular Infectious Disease Market Distribution, by Segment (Molecular Blood Screening - NAT, Molecular HAI [c. diff/sepsis, MRSA, VRE, others], Molecular Hepatitis, Molecular HIV, Molecular Mycobacteria/TB, Molecular Other Microbiology, Molecular STD, Respiratory w/ COVID), 2023 (%)
- Table South Korea Microbiology/Molecular Testing Market Value, by Segment (Blood Screening-NAT, ID/AST, Molecular Dx), 2023-2028 ($M)
- Point-of-Care
- Table South Korea POC Market Value, by Segment (Glucose, Infectious Disease, Other POC), 2023-2028 ($M)
- Histology
- Table South Korea - Histology Market (HPV, CTC, Others), 2023-2028 ($M)
- Market Summary
- Major Market Participants
- Abbott Laboratories
- Table Abbott Corporate Summary
- Company Overview
- Becton Dickinson (BD)
- Table BD Corporate Summary
- Company Overview
- Bertis, Inc
- Table Bertis Corporate Summary
- Company Overview
- bioMerieux SA
- Table bioMerieux SA Corporate Summary
- Company Overview
- Bio-Rad Laboratories Inc.
- Table Bio-Rad Labs Corporate Summary
- Company Overview
- Danaher Corporation
- Table Danaher Corporation Summary
- Company Overview
- Fujirebio Inc
- Table Fujirebio Corporate Summary
- Company Overview
- Gencurix
- Table Gencurix Corporation Summary
- Company Overview
- Roche Diagnostic Corporation
- Table Roche Diagnostic Corporate Summary
- Company Overview
- SD Biosensor
- Table SD Biosensor Corporate Summary
- Company Overview
- Seegene, Inc.
- Table Seegene Corporate Summary
- Company Overview
- Siemens Healthineers GmbH
- Table Siemens Healthineers Corporate Summary
- Company Overview
- Sugentech
- Table Sugentech Corporate Summary
- Company Overview
- Sysmex Corporation
- Table Sysmex Corporate Summary
- Company Overview
- Thermo Fisher Scientific
- Table Thermo Fisher Corporate Summary
- Company Overview
- Abbott Laboratories
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook